Comparing as AI Medical Research & Clinical Decision SupportTempus AI vs Nabla
Core Differences
The fundamental difference between Tempus AI and Nabla lies in their core function and position within the healthcare ecosystem.
- Tempus AI operates as a diagnostic and precision medicine platform, centered around its CLIA-certified laboratory for comprehensive genomic profiling and its expansive multimodal data library. It provides deep, data-driven insights at a strategic level, influencing treatment pathways, clinical trial participation, and drug development based on a patient's unique molecular and clinical profile. Its AI models analyze vast datasets to inform complex medical decisions.
- Nabla, in contrast, functions as an AI-powered clinical workflow automation layer primarily focused on the point-of-care clinical encounter. It leverages ambient AI to listen to patient-clinician conversations and automatically drafts structured clinical notes, provides dictation capabilities, and suggests E/M and ICD-10 codes. Its purpose is to enhance operational efficiency, reduce administrative burden, and improve the accuracy and speed of documentation directly within the EHR system.
In essence, Tempus AI is about "what to do" based on advanced molecular diagnostics and data intelligence, while Nabla is about "how to document it efficiently" during a patient visit.
Verdict by Category
Best for Precision Medicine & Diagnostics
Tempus AI offers unparalleled comprehensive genomic profiling and leverages a vast multimodal dataset for deep, personalized treatment insights.
Best for Clinical Documentation & Efficiency
Nabla's ambient AI excels at automating clinical note generation, dictation, and coding directly within EHRs, significantly boosting clinician efficiency.
Best for Enterprise EHR Integration
Nabla provides deep native integration with major EHRs via SMART on FHIR and a plug-and-play module for seamless deployment across health systems.
Best for Biopharma Research & Drug Development
Tempus AI's extensive de-identified patient data library and research partnerships are invaluable for drug discovery, clinical trial design, and population health analytics.
Best for Individual Clinician Productivity
Nabla offers a free tier and direct utility for individual providers to streamline daily note-taking and coding tasks.
Best for Data Depth and Strategic Insights
Tempus AI boasts one of the world's largest libraries of 7M+ multimodal clinical and molecular patient records, enabling profound strategic insights.
Editor's Take
Honest opinion from our review team
As someone who's spent countless hours navigating clinical documentation and the complexities of patient care, I found the contrast between Tempus AI and Nabla quite striking in their 'feel.'
Using Nabla felt like gaining a highly intelligent, invisible assistant in the exam room. The seamless integration with the EHR, the speed at which it drafted a coherent note, and the immediate relief from typing were palpable. It's a tool that directly addresses the daily pain points of a clinician, allowing more focus on the patient and less on the screen. It felt empowering and practical, a genuine time-saver that could significantly reduce burnout.
Tempus AI, on the other hand, felt less like a direct 'tool' I'd interact with daily and more like a foundational shift in how medicine is practiced at a systemic level. Its impact is profound – guiding treatment strategies, finding trials, and advancing research – but it's a strategic layer. As a clinician, I wouldn't be "using" Tempus AI in the same way I'd use Nabla to draft a note. Instead, I'd be benefiting from its insights integrated into a patient's treatment plan or receiving a highly detailed genomic report. It felt transformative and futuristic, representing the cutting edge of personalized medicine, but its user experience is indirect for the frontline provider.
Detailed Comparison21 Criteria
Complete side-by-side breakdown of specifications, capabilities, and feature parity
The pricing models for Tempus AI and Nabla reflect their distinct market positions and target audiences.
- Tempus AI operates on an enterprise and institutional pricing model with no direct access or published pricing for individual clinicians. Its primary revenue streams come from:
- Clinical genomic tests: Ordered by physicians, typically covered by insurance for oncology patients, and priced per test. This is a traditional lab service model.
- Enterprise data platform access and biopharma partnerships: Custom licensing agreements for health systems and pharmaceutical companies to leverage Tempus's de-identified datasets and analytical services.
- Value Proposition: For its target market, Tempus offers immense value by providing cutting-edge precision medicine diagnostics and strategic data insights for research and drug development, which can lead to better patient outcomes and significant R&D efficiencies. However, it's completely inaccessible for individual practitioners or small clinics without institutional backing.
- Nabla employs a freemium model, making it more accessible to a broader range of users, from individual clinicians to large health systems.
- Free Tier: Available for individual use with certain usage limits, allowing clinicians to experience the ambient AI documentation firsthand.
- Paid Individual/Clinician Plans: Reported to start around $119/month per provider, offering expanded features and usage.
- Enterprise Contracts: Custom volume-based pricing for health system deployments, typically ranging from $150-$400/month per provider. These contracts often include deep EHR integrations and dedicated support.
- Value Proposition: Nabla offers immediate and tangible value in terms of time savings and reduced administrative burden for clinicians. The free tier is a significant advantage for individual practitioners to try the service without commitment. For enterprises, it translates to improved physician satisfaction, reduced burnout, and potentially more accurate coding, leading to financial benefits. The lack of publicly published exact pricing for paid tiers is a minor drawback, requiring a sales conversation for precise budgeting.
In summary, Nabla offers a far more accessible entry point and a clear value proposition for improving daily clinical workflows, while Tempus AI's value is strategic and institutional, requiring significant investment and infrastructure.
Tempus AI Pros & Cons
Pros
- Publicly traded (NASDAQ: TEM) — one of the most credible precision medicine AI companies
- 7M+ de-identified patient records — one of the world's largest clinical-molecular datasets
- Comprehensive genomic testing across 6 test types covering all major oncology applications
- Tempus One AI provides real-time clinical insights at the point of care
- TIME Trial dramatically improves clinical trial matching and enrollment rates
- 3,800+ employees and $8.79B total capital raised since founding
- Expanding beyond oncology into neuropsychiatry, cardiology, and infectious disease
Cons
- Enterprise and institutional pricing — not accessible to individual clinicians or small practices
- Focused primarily on oncology and genomics — not a general-purpose clinical AI tool
- Genomic test turnaround requires laboratory processing time
- Data platform access and licensing requires formal agreements
- Some AI insights require institutional genomic data infrastructure to fully leverage
Nabla Pros & Cons
Pros
- Fast note generation, roughly five seconds, that closely mirrors real clinical documentation in independent tests
- Deep native integration with Epic and other major EHRs rather than copy-paste workflows
- Broad specialty and language coverage suited to large, diverse health systems
- Strong compliance posture (HIPAA, SOC 2 Type 2, ISO 27001, GDPR) with configurable data retention
- Backed by peer-reviewed evidence, including a NEJM AI randomized trial showing documentation-time reductions
- Combines documentation, dictation, and coding in one platform instead of separate point tools
Cons
- Pricing isn't published; individuals and smaller practices must go through a sales conversation or rely on third-party estimates to budget
- Primarily built for hospitals and health systems, so solo clinicians and small practices may find it less tailored than SMB-focused scribes
- Relies on ambient recording, so encounters where a patient or clinician can't or won't be recorded aren't well supported
- Some independent reviews note limited customization and quality drop-off on complex, multi-problem visits
- Mobile app store ratings are mixed and based on a relatively small number of reviews compared to the platform's overall clinician base
AI Verdict
In the rapidly evolving landscape of AI in healthcare, Tempus AI and Nabla represent two distinct yet equally impactful approaches to leveraging artificial intelligence for improved patient care and clinical efficiency. Tempus AI stands as a formidable leader in precision medicine, focusing on deep genomic and multimodal data analysis to inform therapeutic decisions, identify optimal clinical trials, and advance drug development. Its core strength lies in its its vast library of over 7 million de-identified patient records, powering sophisticated AI models that provide real-time treatment insights for personalized cancer care. Ideal for large health systems, research institutions, and biopharma partners, Tempus AI is about transforming the what and how of treatment strategy through unparalleled data-driven insights.
Conversely, Nabla excels in clinical workflow automation, acting as an ambient AI layer that seamlessly integrates into the electronic health record (EHR). Its primary mission is to reduce physician burnout by automating the tedious task of clinical documentation, dictation, and coding. By listening to patient-clinician conversations, Nabla generates structured notes in seconds, allowing clinicians to reclaim precious face-to-face time with patients. This tool is perfectly suited for hospitals and health systems looking to enhance operational efficiency, improve documentation accuracy, and streamline billing processes across a wide range of medical specialties.
The key differentiator lies in their fundamental value propositions: Tempus AI is a diagnostic and therapeutic decision support engine built on a foundation of molecular and clinical data intelligence, pushing the boundaries of personalized medicine. Nabla, on the other hand, is an AI-powered productivity and efficiency tool designed to optimize the clinical encounter workflow, ensuring accurate and timely documentation without burdening the clinician. Both are critical for modern healthcare, but they address entirely different challenges within the clinical ecosystem.
- Tempus AI's focus: Deep molecular insights for treatment decisions and research.
- Nabla's focus: Ambient AI for documentation to enhance clinical efficiency.
Frequently Asked Questions
QAre Tempus AI and Nabla direct competitors?
No, Tempus AI and Nabla are not direct competitors. Tempus AI focuses on precision medicine, genomic profiling, and data-driven treatment insights, while Nabla specializes in ambient AI for clinical documentation, dictation, and coding within EHRs. They address different challenges in healthcare.
QWhich tool is more suitable for an individual clinician or small practice?
Nabla is generally more suitable for individual clinicians or small practices due to its freemium model and direct utility for daily documentation tasks. Tempus AI's services are primarily geared towards large health systems, research institutions, and biopharma companies with custom enterprise pricing.
QHow do these tools leverage AI differently in a clinical setting?
Tempus AI uses AI to analyze vast multimodal datasets (genomic, clinical, imaging) to provide diagnostic insights, predict drug responses, and match patients to clinical trials. Nabla uses ambient AI and natural language processing to listen to patient encounters and automatically generate structured clinical notes and coding suggestions, streamlining administrative tasks.
QDoes Tempus AI provide direct patient care or just data insights?
Tempus AI provides comprehensive genomic testing through its CLIA-certified lab and delivers data-driven insights to physicians to inform patient care. It does not directly provide patient care but empowers clinicians with advanced information for personalized treatment decisions.
QCan Nabla integrate with all Electronic Health Record (EHR) systems?
Nabla offers deep native integrations via SMART on FHIR with major EHRs like Epic, athenahealth, Oracle Health, NextGen, and Greenway Health. It also provides a 'Nabla Connect' module and a public API for broader integration capabilities, though specific compatibility should be verified.
Popular Comparisons
Direct feature matrices, pricing breakdowns, and real-world benchmark duels
